|
MEX3D expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.64224189802553E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.7178480860025E-12 |
| Normal-vs-Stage2 |
7.038400E-03 |
| Normal-vs-Stage3 |
4.62729854433519E-11 |
| Normal-vs-Stage4 |
1.38419997686157E-09 |
| Stage1-vs-Stage2 |
1.003550E-02 |
| Stage1-vs-Stage3 |
6.383800E-01 |
| Stage1-vs-Stage4 |
4.042600E-01 |
| Stage2-vs-Stage3 |
7.864400E-03 |
| Stage2-vs-Stage4 |
3.584200E-03 |
| Stage3-vs-Stage4 |
6.662800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62547753035369E-12 |
| Normal-vs-AfricanAmerican |
1.60125999999483E-05 |
| Normal-vs-Asian |
4.96570000008134E-07 |
| Caucasian-vs-AfricanAmerican |
2.909400E-01 |
| Caucasian-vs-Asian |
3.482800E-01 |
| AfricanAmerican-vs-Asian |
9.686400E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.56714699182248E-12 |
| Normal-vs-Female |
1.69775304925679E-12 |
| Male-vs-Female |
8.312600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.70894418008538E-14 |
| Normal-vs-Age(41-60Yrs) |
2.43870479366137E-11 |
| Normal-vs-Age(61-80Yrs) |
7.5992000003744E-07 |
| Normal-vs-Age(81-100Yrs) |
1.380480E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.648300E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.967670E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.088200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.077200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.959760E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.078770E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.771600E-01 |
| Classical-VS-Follicular |
<1E-12 |
| Classical-VS-Other |
9.232000E-01 |
| Classical-VS-Normal |
<1E-12 |
| Tall-VS-Follicular |
4.99469999803992E-08 |
| Tall-VS-Other |
9.623400E-01 |
| Tall-VS-Normal |
4.89420000082674E-08 |
| Follicular-VS-Other |
2.565000E-03 |
| Follicular-VS-Normal |
2.977200E-01 |
| Other-VS-Normal |
2.089700E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.25580001742298E-09 |
| Normal-vs-N1 |
5.76690029063798E-10 |
| N0-vs-N1 |
1.263500E-03 |
|
|
